Kailera Therapeutics

About:

Kailera Therapeutics is a clinical-stage biotechnology company.

Twitter/X: kaileratx

Top Investors: RTW Investments, Atlas Venture, Bain Capital Life Sciences, Lyra Capital

Description:

Kailera Therapeutics is a clinical-stage biotechnology company that provides revolutionary therapies for treating obesity and related diseases.

Total Funding Amount:

$400M

Headquarters Location:

Waltham, Massachusetts, United States

Founded Date:

2024-01-01

Founders:

Ron Renaud

Number of Employees:

11-50

Last Funding Date:

2024-10-01

IPO Status:

Private

Industries:

Biotechnology